100 results
8-K
EX-99.1
BCLI
Brainstorm Cell Therapeutics, Inc.
16 Apr 24
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
9:31pm
to successfully achieve its goals, BrainStorm's ability to raise additional capital, BrainStorm's ability to continue as a going concern, prospects
8-K
EX-99.1
BCLI
Brainstorm Cell Therapeutics, Inc.
9 Apr 24
BrainStorm Cell Therapeutics Announces Agreement with FDA on a
6:05am
include, without limitation, management's ability to successfully achieve its goals, BrainStorm's ability to raise additional capital, BrainStorm's ability
8-K
EX-99.1
BCLI
Brainstorm Cell Therapeutics, Inc.
1 Apr 24
BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update
8:15am
that are difficult to predict. These potential risks and uncertainties include, without limitation, management's ability to successfully achieve its goals
8-K
EX-99.1
BCLI
Brainstorm Cell Therapeutics, Inc.
20 Dec 23
BrainStorm Issues 2023 Letter to Shareholders
5:04pm
its requisite level by April. We prefer this approach over a reverse stock split, as it aligns more closely with our long-term goals and shareholder … ability to successfully achieve its goals, BrainStorm's ability to raise additional capital, BrainStorm's ability to continue as a going concern
8-K
EX-99.1
fgpm488 ev1b6g0v1j
22 Nov 23
BrainStorm Cell Therapeutics Announces In-Person Meeting with the FDA to Discuss Confirmatory Phase 3 Trial for NurOwn® in ALS
6:03am
8-K
EX-99.1
b7ipfelt8 nw
14 Nov 23
BrainStorm Cell Therapeutics Announces Third quarter 2023 Financial Results and Provides Corporate Update
12:00am
8-K
EX-99.1
qvq9 sde0
24 Oct 23
BrainStorm Cell Therapeutics Announces Strategic Realignment
7:30am
8-K
EX-99.1
na1wdnd0 pier
14 Aug 23
BrainStorm Cell Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
7:21am
424B5
d5qk dhka90hvx
19 Jul 23
Prospectus supplement for primary offering
9:28am
8-K
EX-99.1
h4qylw0gbxj5wqomu
20 Jun 23
BrainStorm Cell Therapeutics Appoints Nir Naor as Board Member and Audit Committee Chair
5:01pm
8-K
EX-99.1
khmjp 49j7d2x
6 Jun 23
Regulation FD Disclosure
8:58am
8-K
EX-99.1
huacyho3 9kar7vskhc
15 May 23
BrainStorm Cell Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update
7:15am
8-K
EX-99.1
k4oxrgbu66
30 Mar 23
BrainStorm Cell Therapeutics Announces Full Year 2022 Financial Results and Provides a Corporate Update
7:18am